Overview

Duloxetine vs. Active Comparator for the Treatment of Depression

Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
How duloxetine compares to a medication currently available for the treatment of depression in the treatment of patients with major depressive disorder. The safety of duloxetine and any side effects that might be associated with it.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride
Venlafaxine Hydrochloride